Safety and Efficacy of KRP203 in Subacute Cutaneous Lupus Erythematosus

Summary

This study will assess the safety and efficacy of KRP203 in clinically active subacute cutaneous lupus erythematosus patients, who have demonstrated inadequate response to standard treatment, such as antimalarials.

Timeline

Start

2011-02

Primary completion

2012-10

Completion

2012-10

Drugs

Indications